Work

Pembrolizumab plus lenvatinib in women with advanced or recurrent uterine carcinosarcoma.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17625

Authors: Qi Wendel Zhang, Jubilee Brown, Erin Crane, Yovanni Casablanca, R. Wendel Naumann

Institution: Levine Cancer Institute

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410813410

FWCI:

Cites:

Cited by:

Related to: 10